South Korea to Start Talks on COVID-19 Drug Remdesivir Purchases in August

Email
Comment *
File	Select/drop/paste files here
Password	(Randomized for file and post deletion; you may also set your own.)
Archive	Archive [500 char limit]
* = required field	[▶ Show post options & limits] Confused? See the FAQ.

Comment *

File

Password

(Randomized for file and post deletion; you may also set your own.)

Archive

Archive [500 char limit]

* = required field

[▶ Show post options & limits]
Confused? See the FAQ.

Embed	(replaces files and can be used instead)
Voice recorder	Show voice recorder (the Stop button will be clickable 5 seconds after you press Record)
Options	Do not bump (you can also write sage in the email field)
Allowed file types:jpg, jpeg, gif, png, webm, mp4 Max filesize is 16 MB. Max image dimensions are 15000 x 15000. You may upload 5 per post.

Embed

(replaces files and can be used instead)

Voice recorder

Show voice recorder

(the Stop button will be clickable 5 seconds after you press Record)

Options

Do not bump
(you can also write sage in the email field)

Allowed file types:jpg, jpeg, gif, png, webm, mp4
Max filesize is 16 MB.
Max image dimensions are 15000 x 15000.
You may upload 5 per post.

South Korea to Start Talks on COVID-19 Drug Remdesivir Purchases in August Veronica 07/02/20 (Thu) 04:02:12 a9c2f7 No.261528

By Reuters

https://www.nytimes.com/section/reuters/news

South Korea has started distributing stocks of the COVID-19 treatment remdesivir that have been donated by Gilead Sciences Inc and plans to begin talks to purchase more supplies in August, its disease control agency said on Wednesday.

It is the first country to disclose a timeline for talks with Gilead. The drugmaker said this week it has priced remdesivir at $390 per vial in developed countries and agreed to allocate nearly all of its supply of the drug to the United States over the next three months.

One of the few treatments shown to alter the course of COVID-19, remdesivir is expected to be in high demand. The intravenously administered medicine has won emergency-use authorisation in several countries and full approval in Japan after a clinical trial showed it helped shorten hospital stays.

https://www.nytimes.com/reuters/2020/07/01/world/asia/01reuters-health-coronavirus-southkorea-remdesivir.html

____________________________

Disclaimer: this post and the subject matter and contents thereof - text, media, or otherwise - do not necessarily reflect the views of the 8kun administration.